Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

214
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
214
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

187
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
187
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

205
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary Anticoagulation Prophylaxis for Children with Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis.

Blood advances·2026
Same author

Platelet extravasation in the microvasculature: an under-appreciated role for platelets.

Frontiers in immunology·2026
Same author

Prevalence of Low Bone Mineral Density Increases With Age in Sickle Cell Disease.

EJHaem·2026
Same author

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10-Year, Single-Institution Experience Encompassing the COVID-19 Pandemic.

Pediatric blood & cancer·2026
Same author

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

Blood advances·2026
Same author

Differential complement activation by alloantibodies in sickle cell hyperhaemolysis syndrome may influence disease course.

British journal of haematology·2026

Related Experiment Video

Updated: Dec 20, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.8K

Microvascular thrombosis: experimental and clinical implications.

Monica A Bray1, Sarah E Sartain1, Jahnavi Gollamudi1

  • 1Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey VA Medical Center, Houston, Texas; Baylor College of Medicine, Houston, Texas.

Translational Research : the Journal of Laboratory and Clinical Medicine
|May 27, 2020
PubMed
Summary

Microvascular thrombosis, often linked with inflammation (thromboinflammation), impacts various diseases including COVID-19. Understanding its regulation is key to developing new treatments for microcirculatory disorders.

More Related Videos

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

16.5K
Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres
08:44

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres

Published on: November 21, 2025

162

Related Experiment Videos

Last Updated: Dec 20, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.8K
Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

16.5K
Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres
08:44

Microvascular Embolism Mouse Model for In Vivo Two-photon Microscopy Using Fluorescent Polystyrene Microspheres

Published on: November 21, 2025

162

Area of Science:

  • Hematology
  • Pathology
  • Microcirculation Research

Background:

  • Thrombosis research traditionally focuses on large vessels.
  • Microvascular thrombosis is implicated in critical diseases like disseminated intravascular coagulation, thrombotic microangiopathy, sickle cell disease, and COVID-19.
  • Microvascular thrombosis in COVID-19 is linked to organ injury pathogenesis.

Purpose of the Study:

  • To review endogenous mechanisms regulating microcirculation thrombosis.
  • To discuss experimental models for inducing microvascular thrombi.
  • To examine clinical conditions associated with microvascular thrombosis.

Main Methods:

  • Review of existing literature on microvascular thrombosis.
  • Analysis of experimental approaches to microvascular thrombus induction.
  • Synthesis of clinical data on diseases involving microvascular thrombosis.

Main Results:

  • Microvascular thrombosis is a common feature in numerous significant human diseases.
  • The association between microvascular thrombosis and inflammation, termed thromboinflammation, is a critical factor.
  • Recent findings highlight microvascular thrombosis in COVID-19 pathogenesis.

Conclusions:

  • Understanding the interplay between inflammation and thrombosis in the microcirculation is crucial.
  • Targeting thromboinflammation pathways may offer novel therapeutic strategies.
  • Further research into microcirculatory thrombosis regulation is needed for improved patient outcomes.